Drug Target Review2025-07-07T13:30:05
Shift Bioscience has published a new study introducing enhanced metrics and baselines for evaluating virtual cell models - boosting gene target discovery and accelerating its rejuvenation therapeutics pipeline.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-31T06:00:00Z
Contributor Dr Davinder Ramsingh, Drug Target Review
2023-06-20T12:34:32
Sponsored by NanoTemper Technologies
2025-05-14T14:30:00
Sponsored by Abzena
2026-05-22T07:38:00
Contributor Dr Helen Bright, Drug Target Review
2025-06-02T10:00:00
Contributor Professor Stefan Trapp, Drug Target Review
2023-02-02T11:05:15
Sponsored by Cell Signaling Technology
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
Site powered by Webvision Cloud